Aberrant peripheral blood CD34+ subsets as a candidate cellular biomarker for type 2 diabetes mellitus

Practical Laboratory Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles